A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

NCT00845026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: LY2140023
DRUG: aripiprazole
DRUG: olanzapine
DRUG: risperidone

Sponsor

Denovo Biopharma LLC